Walleye Capital LLC Assembly Biosciences, Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.46 - $2.45 $110,038 - $184,654	-75,369 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$2.13 - $3.46 $8,933 - $14,511	4,194 Added 5.89%	75,369 $175,000
Q3 2021 Nov 15, 2021	BUY	$3.14 - $3.9 $223,489 - $277,582	71,175 New	71,175 $248,000
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $305,991 - $367,189	-80,524 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.33 - $6.63 $87,652 - $134,211	-20,243 Reduced 20.09%	80,524 $370,000

Q4 2020 Feb 16, 2021	BUY	$4.87 - $17.29 $490,735 - $1.74 Million	100,767 New	100,767 $610,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $665M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.